130 related articles for article (PubMed ID: 8089899)
1. From the Food and Drug Administration.
Nightingale SL
JAMA; 1994 Oct; 272(13):995. PubMed ID: 8089899
[No Abstract] [Full Text] [Related]
2. Aplastic anemia in a patient receiving felbamate for complex partial seizures.
Pennell PB; Ogaily MS; Macdonald RL
Neurology; 1995 Mar; 45(3 Pt 1):456-60. PubMed ID: 7898696
[TBL] [Abstract][Full Text] [Related]
3. FDA recommends taking patients off Felbatol.
RDH; 1994 Sep; 14(9):36. PubMed ID: 8619071
[No Abstract] [Full Text] [Related]
4. Evaluation of case reports of aplastic anemia among patients treated with felbamate.
Kaufman DW; Kelly JP; Anderson T; Harmon DC; Shapiro S
Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520
[TBL] [Abstract][Full Text] [Related]
5. Felbamate: restrictions on use.
Farrington E
Pediatr Nurs; 1995; 21(2):188, 200. PubMed ID: 7746687
[No Abstract] [Full Text] [Related]
6. Felbamate: 1997 update.
Pellock JM; Brodie MJ
Epilepsia; 1997 Dec; 38(12):1261-4. PubMed ID: 9578519
[No Abstract] [Full Text] [Related]
7. 27-year-old woman with pancytopenia.
Rayson D; Kang EM; Inwards DJ
Mayo Clin Proc; 1995 Feb; 70(2):185-8. PubMed ID: 7845045
[No Abstract] [Full Text] [Related]
8. Taming the brain storms: felbamate updated.
Brodie MJ; Pellock JM
Lancet; 1995 Oct; 346(8980):918-9. PubMed ID: 7564721
[No Abstract] [Full Text] [Related]
9. Acute liver failure linked to felbamate use.
Am J Hosp Pharm; 1994 Dec; 51(23):2882, 2887. PubMed ID: 7879797
[No Abstract] [Full Text] [Related]
10. Felbamate-associated fatal acute hepatic necrosis.
O'Neil MG; Perdun CS; Wilson MB; McGown ST; Patel S
Neurology; 1996 May; 46(5):1457-9. PubMed ID: 8628501
[TBL] [Abstract][Full Text] [Related]
11. Felbamate as add-on therapy.
Li LM; Nashef L; Moriarty J; Duncan JS; Sander JW
Eur Neurol; 1996; 36(3):146-8. PubMed ID: 8738944
[TBL] [Abstract][Full Text] [Related]
12. Felbamate linked to aplastic anemia; warning issued on drug's use.
Am J Hosp Pharm; 1994 Oct; 51(19):2324. PubMed ID: 7847395
[No Abstract] [Full Text] [Related]
13. New antiepilepsy drug, felbamate, marketed.
Clin Pharm; 1993 Oct; 12(10):713. PubMed ID: 8258253
[No Abstract] [Full Text] [Related]
14. Felbamate.
Pellock JM
Epilepsia; 1999; 40 Suppl 5():S57-62. PubMed ID: 10530695
[TBL] [Abstract][Full Text] [Related]
15. The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame?
Thakkar K; Billa G; Rane J; Chudasama H; Goswami S; Shah R
Expert Rev Neurother; 2015; 15(12):1373-5. PubMed ID: 26566191
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV
Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
[TBL] [Abstract][Full Text] [Related]
17. Is there any future for felbamate treatment?
Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ
Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558
[TBL] [Abstract][Full Text] [Related]
18. Psychosis associated with felbamate treatment.
Knable MB; Rickler K
J Clin Psychopharmacol; 1995 Aug; 15(4):292-3. PubMed ID: 7593718
[No Abstract] [Full Text] [Related]
19. Felbamate.
Sofia RD; Kramer L; Perhach JL; Rosenberg A
Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064
[No Abstract] [Full Text] [Related]
20. Felbamate: a new antiepileptic drug.
Brodie MJ
Lancet; 1993 Jun; 341(8858):1445-6. PubMed ID: 8099147
[No Abstract] [Full Text] [Related]
[Next] [New Search]
